Mercury induces cytotoxicity and transcriptionally activates stress genesin human liver carcinoma (HepG2) cells

International Journal of Molecular Sciences

Volumn 3, Issue 9, 2002, Pages 965-984

  Sutton, Dwayne J ^a   Tchounwou, Paul B ^a   Ninashvili, Nanuli ^a   Shen, Elaine ^b  

^a Jackson State University ^*  (United States)

^b Xenometrix Inc USA   (United States)

Author keywords

Cytotoxicity; Gene expression; Mercury

Indexed keywords

(4,5 DIMETHYLTHIAZOL 2YL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROMINE DERIVATIVE; CHLORAMPHENICOL ACETYLTRANSFERASE; MERCURY; MERCURY CHLORIDE; PROTEIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOTRANSFORMATION; CARCINOGENESIS; CELL DAMAGE; CELL LEVEL; CELL LINE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; EXPOSURE; GENE EXPRESSION; GENE INDUCTION; GROWTH DISORDER; HUMAN; HUMAN CELL; LETHAL DOSE; LIVER CARCINOMA; MERCURIALISM; MUTAGENESIS; PROMOTER REGION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 3242768443     PISSN: 14220067     EISSN: None     Source Type: Journal    
DOI: 10.3390/i3090965     Document Type: Article

References (71)

1. ATSDR/EPA. Priority List for 1999; Top 20 Hazardous Substances, Agency For Toxic Substance and Disease Registry. U. S. Department of Health and Human Services. 1999, on line at: http://www.atsdr.cdc.gov/99/list.html.
2. NAS. An assessment of mercury in the environment. National Academy of Science Press, Washington, D.C., 1978.
3. Nriagu, J.O. Production and uses of mercury. In the biogeochemistry of mercury in the environment. Elsevier, Amsterdam, pp. 23-40, 1979.
4. Goyer, R. A. "Toxic effects of metals" in: Caserett and Doull's Toxicology - The basic science of poisons. McGraw-Hill, Inc., N.Y., 1993.
5. WHO. Inorganic mercury, Environmental Health Criteria 118. World Health Organization. 1991.
6. U.S. EPA (1997a). Mercury study report to congress, volume III: Fate and transport of mercury in the environment. U.S. Environmental Protection Agency, Office of Air Quality Planning & Standards and Office of Research and Development. EPA-452/R-97-005. NTIS number: PB98-124753, 1997.
7. Glass, G.E.; Sorensen, J.A.; Schmidt, K.W.; Rapp, G. R. New source identification of mercury contamination in the Great Lakes. Environ. Sci. Technol.. 1990, 24:1059-1069.
8. IRIS. Methyl mercury. Integrated Risk Information Service, last revised on 07/27/2001. Washington, D.C.; U.S. Environmental Protection Agency (U.S. EPA), 2001.
9. Trakhtenberg, L.M. Chronic effects of mercury on organisms. U.S. Department of Health, Education, and Welfare Public Health Service National Institutes of Health DHEW Publication No. (NIH) 74-473, 1974.
10. Kozik, M.B.; Gramza, G. Histochemical changes in the neurosecretory hypothalic nuclei as a result of an intoxification with mercury compounds. Acta Histochem. Suppl. 1980, 22, 367-380.
11. Gonzalez-Ramirez, D. et al; Urinary mercury, porphyrins, and neurobehavioral changes of Dental workers in Monterrey, Mexico. J. Pharmocology and Experimental Therapeutics. 1995, 272(1), 264-274.
12. Olanow, C.W.; Arendash, G.W. Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 1994, 7(6), 548-558.
13. Johnson, S. The possible role of gradual accumulation of copper, cadmium, lead, and iron depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypotheses. 2000, 55(3), 239-241.
14. nd revised edition, 1999.
15. Boot, J.H. Effects of SH-blocking compounds on the energy metabolism in isolated rat hepatocytes. Cell. Struct. Funct. 1995, 20(3), 233-238.
16. Matts, R.L.; Schatz, J.R.; Hurst, R.; Kagen, R. Toxic heavy metal ions inhibit reduction of disulfide bonds. J. Biol Chem. 1991, 266(19), 12695-12703.
17. Khera et al. Teratogenic and genetic effects of mercury toxicity. Teratology. 1990, 8, 293-304.
18. O'Halloran, T.V. Transition metals in control of gene expression. Science 1993, 261(5122), 715-725.
19. Goyer, R.A. Nutrition and metal toxicity. Am. J. Clin. Nutr. 1995, 61(suppl 3), 545S-650S.
20. Kubicka et al. Autoimmune disease induced by mercuric chloride. Int Arch Allergy Immunol. 1996, 109(1), 11-20.
21. McFadden, S.A. Xenobiotic metabolism and adverse environmental response: sulfur dependent detoxification pathways. Toxicology. 1996, 111(1-3), 43-65.
22. Srikantarah, M.V.; Radjakushnan, A. N. Studies on the metabolism of vitamin B6 in the small intestine. Purification and properties of monkey intestinal pyridoxal kinases. Indian J. Biochem. 1970, 7(3), 151-156.
23. Veltman, J.C. Alterations of heme cytochrome P-450, and steroid metabolism by mercury in rat adrenal gland. Arch Biochem Biophys. 1986, 248(2), 467-478.
24. Danielson, B.R. Ferotoxicity of inorganic mercury: Distribution and effect of nutrient uptake by placenta and fetus. Neurotoxicol. Teratol. 1984, 18, 129-134.
25. Kubicka-Murranyi, M. "Systemic autoimmune disease induced by mercuric chloride. Int Arch Allergy Immunol. 1996, 109(1), 11-20.
26. U. S. EPA. Mercury study report to congress. Volume V: Health effects of mercury and mercury compounds. U. S. Environmental Protection Agency, Office of Air Quality Planning and Standards and Office of Research and Development. EPA-452/R-97-005. NTIS number: PB98-12444753, 1997.
27. WHO. Inorganic mercury volume 118. Geneva, Switzerland: World Health Organization, 1991.
28. IRIS. Mercuric chloride. Integrated Risk Information Service, last revised on 4/01/97. Washington, D.C.; U.S. Environmental Protection Agency (U.S. EPA), 1997.
29. Kaik, P. Clinical and neurochemical aspects of inorganic mercury intoxification. In handbook of clinical neurology, Elsevier, Amsterdam, 36, 147-197, 1979.
30. Takizawa, Y. The epidemiology of mercury poisoning. In the biogeochemistry of mercury in the environment, Nriagu, J.O. eds Elsevier, Amsterdam pp. 325-366, 1979.
31. Todd, M.D.; Lee, M.J.; Williams, J.L.; Nalenzy, J.M.; Gee, P.; Benjamin, M.B.; Farr, S.B. The CAT-Tox (L) assay: A sensitive and specific measure of stress induced transcription in transformed liver cells. Fundam. Appl. Toxicol. 1995, 28, 118-128.
32. Tchounwou, P.B.; Wilson, B.A.; Schneider, J.; Ishaque, A. Cytogenic assessment of arsenic trioxide toxicity in the Mutatox, Ames II and CAT-Tox assays. Metal Ions Biol. Med. 2000, 6, 89-91.
33. Todd, M.D.; Lee, M.J.; Williams, J.L.; Nalenzy, J.M.; Gee, P.; Benjamin, M.B.; Farr, S.B. The CAT-Tox (L) assay: A sensitive and specific measure of stress induced transcription in transformed liver cells. Fundam. Appl. Toxicol. 1995, 28, 118-128.
34. Tchounwou, P.B. Health risk assessment and management of arsenic and other hazardous metals in drinking water. Metal Ions Biol. Med. 2000, 6, 21-23.
35. 2) exposed to cadmium chloride. Molecular and Cellular Biochemistry. 2001, 222, 21-28.
36. 2) cells. Metal Ions in Biology and Medicine. 2002, 7, 132-137.
37. 2 cells. Toxicology and Applied Pharmacology. 2000, 168, 79-90.
38. Olivieri, G.; Brack, C.; Muller-Spahn, F.; Stahelin, H.B.; Herrmann, M.; Renard, P.; Brockhaus, M.; Hock, C. Mercury induces cell cytotoxicity and oxidative stress and increases β-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. Journal of Neurochemistry. 2000, 74, 231-236.
39. Shenker, B.J.; Guo, T.L.; Shapiro, I.M. Mercury induced apoptosis in human Lymphoid cells: Evidence that the apoptotic pathway is mercurial species dependent. Environmental Research. 2000, 84, 89-99.
40. 2). Env. Toxicol. Risk Assessment 2000, 10, 83-95.
41. nd edition, Frieberg, G.R.; Norber, V.B.; Vouk, B. ed. New York:Elsevier Press. 1980.
42. ATSDR. Toxicological Profile for Mercury: TP-93/10. Agency for Toxic Substance And Disease Registry. Centers for Disease Control. Atlanta, Georgia, 1994.
43. th edition, Baltimore, Maryland: Williams and Wilkins, pp. III262-III275. 1984.
44. Troen, P.; Kaufman, S.; Katz, K.H. Mercuric bichloride poisoning. New England J. Med. 1951, 244, 459-463.
45. Rushmore, T.H.; Pickett, C.B. Glutathione S-transferases: structure, regulation, and therapeutic implications. J. Biol. Chem.. 1993, 268, 11475-11478.
46. Rushmore, T.H.; King, R.G.; Paulson, K.E.; Pickett, C.B. Regulation of glutathione S-transferase Ya subunit gene expression: Identification of a unique xenobiotic responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci.. 1990, 87, 3826-3830.
47. Zalups, R.K.; Lash, L.H. Interactions between glutathione and mercury in the kidney, liver and blood. In: Chang, L.W., ed. Toxicology of Metals. Boca Raton: CRC Press; 1996:145-163.
48. Hamer, D.H. Metallothionein. Ann. Rev. Biochem.. 1986, 55, 913-951.
49. Burman, D.M.; Palmiter, R.D. Analysis of detoxification of heavy metal ions by mouse metallothionein. EXS.. 1987, 52, 457-463.
50. Klassen, C.D.; Liu, J. Induction of metallothionein as an adaptive mechanism affecting the magnitude and progression of toxicological injury. Environ. Health Perspect.. 1998, 106, 297-300.
51. Mosser, D.D.; Duchanie, J.; Massie, B. The DNA-binding activity of the human heat shock transcription factor is regulated in vivo by hsp70. Mol. Cell. Biol.. 1993, 13, 5427-5438.
52. Mosser, D.D.; Theodorakis, N.G.; Morimoto, R.I. Coordinate changes in heat shock element binding activity and HSP70 gene transcription rates in human cells. Mol. Cell. Biol.. 1988, 8, 3733-3736.
53. Hartl, F.U.; Martin, J.; Neupert, W. protein folding in the cell: The role of molecular chaperones HSP70 and HSP60. Annu. Rev. Biophys. Biomol. Struct.. 1992, 21, 293-322.
54. Delmas, R.; Schaak, S.; Gaubin, Y.; Croute, F.; Arrabit, C.; Murat, J. C. HSP72 mRNA production in cultured human cells submitted to non-lethal aggression by heat, ethanol, or propanol. Application to the detection of low concentration of chromium (VI) (potassium dichromate). Cell. Biol. Toxicol.. 1998, 14, 39-46.
55. 2 and methyl mercury in astrocytes: selectivity and reversibility. Journal of Neurochemistry. 1989, 53(4), 1228-1237.
56. Wooden, S.K.; Li, L.J.; Navarro, D.; Qadri, I.; Pereira, L.; Lee, A.S. Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif, which interacts with CTF/NF-1. Mol. Cell. Biol.. 1991, 11, 5612-5623.
57. Buscher, M.; Rahmsdorf, M; Litfin, M.; Herrlich, P. Activation of the c-fos gene by UV and phorbol ester: different signal pathways converge to the same enhancer element. Oncogene. 1988, 3, 301-311.
58. Gilman, M.Z. The c-fos serum response element responds to protein kinase c-dependent and independent signals but not to cyclic AMP. Genes Dev.. 1988, 2, 394-399.
59. Berkowitz, L.A.; Riabowal, K.T.; Gilman, M.Z. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol. Cell. Biol.. 1989, 9, 4722-4731.
60. Sassosne-Corsi, P; Visvander, J.; Ferland, L; Mellon, P.; Verma, L.N. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of cAMP response element. Genes Dev.. 1988, 2, 1529-1538.
61. Bading, H.; Ginty, D.D.; Greenbert, M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathway. Science, 1993, 260, 181-186.
62. Ginty, D.D.; Bonni, A.; Greenberg, M.E. Nerve growth factor activates a Ras dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 1994, 77, 713-725.
63. Greenberg, M.E.; Ziff, E.B.; Green, L.A. Stimulation of neuronal acetylcholine receptors induce rapid gene transcription. Science. 1986, 234, 80-83.
64. Angel, P. Karin, M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta. 1991, 1072, 129-157.
65. Borrelli, E.; Montmayeur, J.P.; Foulkes, N.S.; Sassone-Corsi, P. Signal transduction and gene control:The cAMP pathway. Crit. Rev. Oncog.. 1992, 3, 321-338.
66. Fornace, A.J. Jr.; Nerbert, D.W.; Hollander, M.C.; Leuthy, J.D.; Papthanasiou, M.; Fargnoli, J.; Holbrook, N.J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 1989, 9, 4196-4203.
67. Hollander, M.C.; Alamo, L.; Jackman, J.; Wang, M.G.; McBride, O.W., Fornace, A.J., Jr. Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem.. 1993, 268, 24384-24393.
68. Bartlett, J.D.; Leuthy, J.D.; Carlson, S.G.; Sollott, S.J.; Holbrook, N.J. Calcium ionophore A23178 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, gadd153. J. Biol. Chem.. 1992, 267, 20465-20470.
69. Kastan, M.B.; Onyekwere, O.; Sidransky, D.; Vogelstein, B.; Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res.. 1991, 51, 6304-6311.
70. Vogelstein, B.; Kinzler, K.W. p53 function and dysfunction. Cell 1992, 70, 523-526.
71. Zhan, Q.; Carrier, F.; Fornace, A.J. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol.. 1993, 13, 4242-4250.